- Report
- June 2026
- 191 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- November 2025
- 183 Pages
Global
From €4035EUR$4,500USD£3,460GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,181USD£3,106GBP
- Report
- January 2026
- 180 Pages
Global
From €3179EUR$3,545USD£2,726GBP
€3532EUR$3,939USD£3,029GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,453GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,453GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,453GBP
- Report
- April 2026
- 433 Pages
Global
From €7165EUR$7,990USD£6,144GBP
- Report
- May 2026
- 400 Pages
Global
From €3470EUR$3,869USD£2,975GBP
- Report
- April 2026
- 160 Pages
Global
From €2977EUR$3,320USD£2,553GBP
€3722EUR$4,150USD£3,191GBP
- Report
- March 2026
- 500 Pages
Global
From €4479EUR$4,995USD£3,841GBP
- Report
- August 2026
- 262 Pages
Global
From €6273EUR$6,995USD£5,379GBP
- Report
- August 2026
- 388 Pages
Global
From €6273EUR$6,995USD£5,379GBP
- Report
- August 2026
- 281 Pages
Global
From €6273EUR$6,995USD£5,379GBP
- Report
- December 2025
- 391 Pages
Global
From €4304EUR$4,799USD£3,690GBP
- Report
- October 2025
- 598 Pages
Global
From €4304EUR$4,799USD£3,690GBP
- Report
- April 2026
- 424 Pages
Global
From €5251EUR$6,060USD£4,350GBP
- Report
- February 2026
- 320 Pages
Global
From €4439EUR$4,950USD£3,806GBP
- Report
- February 2026
- 656 Pages
Global
From €4304EUR$4,799USD£3,690GBP
- Report
- March 2026
- 184 Pages
Global
From €4304EUR$4,799USD£3,690GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more